How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Sell
41
GRX Quote, Financials, Valuation and Earnings
Last price:
$9.70
Seasonality move
:
1.61%
Day range:
$9.65 - $9.94
52-week range:
$9.16 - $11.24
Dividend yield:
0.2%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
17.1K
Avg. volume:
30.3K
1-year change:
4.64%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingGabelli Healthcare & WellnessRx Trust has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Gabelli Healthcare & WellnessRx Trust has an estimated downside of -- from its current price of $9.70.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $9.70.
Fair Value
-
According to the consensus of 0 analysts, Gabelli Healthcare & WellnessRx Trust has -- downside to fair value with a price target of -- per share.
GRX vs. S&P 500
-
Over the past 5 trading days, Gabelli Healthcare & WellnessRx Trust has underperformed the S&P 500 by -3.36% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Gabelli Healthcare & WellnessRx Trust does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Gabelli Healthcare & WellnessRx Trust has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Gabelli Healthcare & WellnessRx Trust reported revenues of --.
Earnings Growth
-
Gabelli Healthcare & WellnessRx Trust has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Gabelli Healthcare & WellnessRx Trust reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-27 | 2023-12-27 | 2023-12-27 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $405.5K | $380.9K | $5.1M | |
| Total Assets | -- | -- | $272.3M | $307M | $286.5M | |
| Current Liabilities | -- | -- | $560.3K | $1.1M | $4M | |
| Total Liabilities | -- | -- | $688.3K | $1.3M | $44.3M | |
| Total Equity | -- | -- | $271.6M | $305.8M | $242.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-27 | 2023-12-27 | 2023-12-27 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
GRX
Sector
Market Cap
--
--
Price % of 52-Week High
86.74%
--
Dividend Yield
0.2%
--
Shareholder Yield
--
--
1-Year Price Total Return
5.75%
--
Beta (5-Year)
1.060
--
Dividend yield:
0.2%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$9.73
200-day SMA
Sell
Level
$10.17
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$10.12
Relative Strength Index (RSI14)
Sell
Level
31.46
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-76.5217
50-day SMA
Sell
Level
$10.30
MACD (12, 26)
Sell
Level
-0.20
25-day Aroon Oscillator
Sell
Level
-44
On Balance Volume
Neutral
Level
--
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
Stock Forecast FAQ
In the current month, GRX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GRX average analyst price target in the past 3 months is --.
-
Where Will Gabelli Healthcare & WellnessRx Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Gabelli Healthcare & WellnessRx Trust share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Gabelli Healthcare & WellnessRx Trust?
Analysts are divided on their view about Gabelli Healthcare & WellnessRx Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Gabelli Healthcare & WellnessRx Trust is a Sell and believe this share price will rise from its current level to --.
-
What Is Gabelli Healthcare & WellnessRx Trust's Price Target?
The price target for Gabelli Healthcare & WellnessRx Trust over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GRX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Gabelli Healthcare & WellnessRx Trust is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GRX?
You can purchase shares of Gabelli Healthcare & WellnessRx Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Gabelli Healthcare & WellnessRx Trust shares.
-
What Is The Gabelli Healthcare & WellnessRx Trust Share Price Today?
Gabelli Healthcare & WellnessRx Trust was last trading at $9.70 per share. This represents the most recent stock quote for Gabelli Healthcare & WellnessRx Trust. Yesterday, Gabelli Healthcare & WellnessRx Trust closed at $9.70 per share.
-
How To Buy Gabelli Healthcare & WellnessRx Trust Stock Online?
In order to purchase Gabelli Healthcare & WellnessRx Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is up 49.85% over the past day.
Buy
60
QMCO alert for Dec 27
Quantum [QMCO] is up 49.62% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is up 10.88% over the past day.
